Page last updated: 2024-10-26

diclofenac and Atypical Ductal Hyperplasia

diclofenac has been researched along with Atypical Ductal Hyperplasia in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"Women at high risk of breast cancer and those with carcinoma in situ need non-toxic, well-tolerated preventive interventions."2.80Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation. ( Allu, S; Bethke, KP; Chatterton, RT; Hansen, NM; Helenowski, I; Ivancic, D; Kenney, K; Khan, SA; Lee, O; Muzzio, M; Scholtens, D; Shidfar, A; Sullivan, ME, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, O1
Ivancic, D1
Allu, S1
Shidfar, A1
Kenney, K1
Helenowski, I1
Sullivan, ME1
Muzzio, M1
Scholtens, D1
Chatterton, RT1
Bethke, KP1
Hansen, NM1
Khan, SA1

Trials

1 trial available for diclofenac and Atypical Ductal Hyperplasia

ArticleYear
Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Animals; Antineoplastic Agents; Breast; Brea

2015